| P50 | author | Edythe D. London | Q5346986 |
| | Shahrdad Lotfipour | Q59157540 |
| | Rachel F Tyndale | Q60463126 |
| | Paul Faulkner | Q89610356 |
| | Nicole Petersen | Q91890901 |
| | Chelsea M Cox | Q125317086 |
| P2093 | author name string | Gerhard S Hellemann | |
| | Dara G Ghahremani | |
| | Celia Vigil | |
| | Neil Paterson | |
| | Ari S Kazanjian | |
| P2860 | cites work | Nicotine replacement therapy for smoking cessation | Q24242851 |
| | Mortality in relation to smoking: 50 years' observations on male British doctors | Q24563394 |
| | Smoking and mortality--beyond established causes | Q28256793 |
| | Development and validation of brief measures of positive and negative affect: The PANAS scales | Q29614730 |
| | Predictive reward signal of dopamine neurons | Q29615397 |
| | Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence | Q34029147 |
| | Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers | Q34135377 |
| | Randomized Trial of Reduced-Nicotine Standards for Cigarettes. | Q34496332 |
| | Effects of abstinence from tobacco: valid symptoms and time course | Q34577868 |
| | A quantitative analysis of subjective, cognitive, and physiological manifestations of the acute tobacco abstinence syndrome | Q35148815 |
| | Nicotine, carbon monoxide, and carcinogen exposure after a single use of a water pipe. | Q35535816 |
| | The reliability and predictive validity of the Heaviness of Smoking Index and its two components: Findings from the International Tobacco Control Four Country study | Q35839040 |
| | Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine | Q35892758 |
| | Nicotine metabolite ratio (3-hydroxycotinine/cotinine) in plasma and urine by different analytical methods and laboratories: implications for clinical implementation | Q35920608 |
| | Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes | Q35947187 |
| | Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes. | Q35974959 |
| | Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up. | Q36047868 |
| | Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls | Q36471948 |
| | The influence of nicotine dose and nicotine dose expectancy on the cognitive and subjective effects of cigarette smoking | Q36865243 |
| | Reduced nicotine content cigarettes and nicotine patch | Q36927046 |
| | Subjective responses to oral tobacco products: scale validation | Q36929850 |
| | Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers | Q36974499 |
| | Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking | Q37206730 |
| | Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette | Q37412757 |
| | Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette | Q37422715 |
| | Current Cigarette Smoking Among Adults - United States, 2005-2015. | Q39198854 |
| | Nicotine delivery kinetics and abuse liability | Q40782278 |
| | Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate | Q41950690 |
| | Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine | Q42418777 |
| | Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. | Q43548064 |
| | Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes | Q43638190 |
| | Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking | Q44206077 |
| | Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity | Q44960529 |
| | Establishing a nicotine threshold for addiction. The implications for tobacco regulation | Q46058830 |
| | Placebo cigarettes in a spaced smoking paradigm | Q46490694 |
| | Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. | Q46664328 |
| | Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette | Q46897472 |
| | Multiple neuronal networks mediate sustained attention | Q48146837 |
| | Signs and symptoms of tobacco withdrawal | Q49016637 |
| | High density of nicotinic receptors in the cingulo-insular network. | Q51029318 |
| | Dissociating nicotine and nonnicotine components of cigarette smoking. | Q51072196 |
| | Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI. | Q51814006 |
| | Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. | Q52007821 |
| | Smoking and Mortality — Beyond Established Causes | Q60155019 |
| | Smoking withdrawal symptoms in two weeks of abstinence | Q67532351 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nicotine | Q12144 |
| P304 | page(s) | 1610-1618 | |
| P577 | publication date | 2017-01-24 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects | |
| P478 | volume | 42 | |